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Krishnan V, Maddox JW, Rodriguez T, Gleason E. A role for
the cystic fibrosis transmembrane conductance regulator in the nitric
oxide-dependent release of Cl⫺ from acidic organelles in amacrine
cells. J Neurophysiol 118: 2842–2852, 2017. First published August
23, 2017; doi:10.1152/jn.00511.2017.—␥-Amino butyric acid (GABA)
and glycine typically mediate synaptic inhibition because their ligandgated ion channels support the influx of Cl⫺. However, the electrochemical gradient for Cl⫺ across the postsynaptic plasma membrane
determines the voltage response of the postsynaptic cell. Typically,
low cytosolic Cl⫺ levels support inhibition, whereas higher levels of
cytosolic Cl⫺ can suppress inhibition or promote depolarization. We
previously reported that nitric oxide (NO) releases Cl⫺ from acidic
organelles and transiently elevates cytosolic Cl⫺, making the response
to GABA and glycine excitatory. In this study, we test the hypothesis
that the cystic fibrosis transmembrane conductance regulator (CFTR)
is involved in the NO-dependent efflux of organellar Cl⫺. We first
establish the mRNA and protein expression of CFTR in our model
system, cultured chick retinal amacrine cells. Using whole cell voltage-clamp recordings of currents through GABA-gated Cl⫺ channels,
we examine the effects of pharmacological inhibition of CFTR on the
NO-dependent release of internal Cl⫺. To interfere with the expression of CFTR, we used clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 genome editing. We find that both
pharmacological inhibition and CRISPR/Cas9-mediated knockdown
of CFTR block the ability of NO to release Cl⫺ from internal stores.
These results demonstrate that CFTR is required for the NO-dependent efflux of Cl⫺ from acidic organelles.
NEW & NOTEWORTHY Although CFTR function has been studied extensively in the context of epithelia, relatively little is known
about its function in neurons. We show that CFTR is involved in an
NO-dependent release of Cl⫺ from acidic organelles. This internal
function of CFTR is particularly relevant to neuronal physiology
because postsynaptic cytosolic Cl⫺ levels determine the outcome of
GABA- and glycinergic synaptic signaling. Thus the CFTR may play
a role in regulating synaptic transmission.
CFTR; cytosolic chloride; amacrine cells; nitric oxide

and organellar Cl⫺ is critical to
normal cellular physiology (reviewed in Faundez and Hartzell
2004; Stauber and Jentsch 2013). In neurons, cytosolic Cl⫺ has
the additional role of determining the sign of GABA- and
glycinergic synapses. When postsynaptic cytosolic Cl⫺ levels
are low and the equilibrium potential for Cl⫺ is quite negative,
GABA and glycine will cause inhibition. If postsynaptic cytoTHE REGULATION OF CYTOSOLIC
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solic Cl⫺ levels are elevated, however, inhibition is either
reduced or is converted to excitation (Kaila et al. 2014).
Amacrine cells are retinal interneurons that receive depolarizing input from glutamatergic bipolar cells and make primarily
inhibitory GABA- and glycinergic synapses onto retinal ganglion cells that then send the retinal signal to higher visual
centers. The most common synaptic interactions for amacrine
cells, however, are with other amacrine cells (Marc and Liu
2000). Additionally, amacrine cell dendrites can have adjacent
pre- and postsynaptic sites, making regulation of local Cl⫺
levels especially important.
Our laboratory demonstrated that nitric oxide (NO) can elicit
the release of Cl⫺ from acidic organelles (Hoffpauir et al.
2006; Krishnan and Gleason 2015) and that this release is itself
dependent on transient cytosolic acidification (McMains and
Gleason 2011). However, the transporter(s) mediating this
NO-dependent internal Cl⫺ release has remained elusive.
Many of the pharmacological modulators of Cl⫺ channels and
transporters lack specificity or are unavailable, making the
mediators of this Cl⫺ efflux pathway challenging to identify.
The cystic fibrosis transmembrane conductance regulator
(CFTR) is a good candidate for involvement in this mechanism, because CFTR currents can be potentiated by cytosolic
acidification (Chen et al. 2009).
The CFTR is a member of the ATP binding cassette transporter family that functions as an ATP- and phosphorylationdependent anion channel that supports the flux of Cl⫺ (reviewed in Hwang and Sheppard 2009). This channel has been
extensively studied in the context of epithelia because of the
deleterious effects of its mutated forms in cystic fibrosis
(Riordan et al. 1989). The most common mutation, ⌬F508,
leads to abnormal folding of the protein and reduced trafficking
to the epithelial apical plasma membrane (Wang and Li 2014).
CFTR expression is not, however, confined to epithelia. For
example, it is expressed in cardiovascular system in cell types
such as cardiac myocytes (Gadsby et al. 1995), endothelial
cells (Tousson et al. 1998), and immune cells (Di et al. 2006;
Painter et al. 2006). Other examples of CFTR-expressing cell
types include smooth muscle (Vandebrouck et al. 2006), skeletal muscle (Tu et al. 2010), osteoblasts (Shead et al. 2007),
and neurons (Guo et al. 2009a, 2009b; Mulberg et al. 1995).
The limited number of functional studies in neurons demonstrate a role for CFTR in regulating cytosolic Cl⫺ (Morales
et al. 2011; Ostroumov et al. 2011), nonvesicular ATP release
(Kanno and Nishizaki 2011), glucose sensing by hypothalamic
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neurons (Chalmers et al. 2014; Murphy et al. 2009), exocytosis
(Weyler et al. 1999), and peripheral nerve myelination
(Reznikov et al. 2013). In addition to its well-established
expression at the plasma membrane, CFTR can be active in
multiple acidic organelles, including the trans-Golgi (Barasch
et al. 1991), endosomes (Biwersi and Verkman 1994), and
lysosomes (Liu et al. 2012).
To explore the involvement of CFTR in the NO-dependent release of Cl⫺ from acidic organelles, we first investigated the expression of CFTR in retinal amacrine cells by
looking for the presence of both mRNA and protein. We
then examined the effects of selective pharmacological
inhibition of CFTR function. Finally, we determined the
consequences of inhibiting the expression of CFTR with a
CRISPR/Cas9 gene editing strategy. Our results demonstrate that CFTR is expressed by amacrine cells and that it
is required for the NO-dependent release of Cl⫺ from acidic
organelles.
MATERIALS AND METHODS

All methods involving animals have been approved by the Louisiana State University Institutional Animal Care and Use Committee.
Cell culture. Retinal cultures were derived from chick embryos by
using the methods described in Krishnan and Gleason (2015). For
experiments involving CFTR inhibitors (see Figs. 2 and 3), retinas
were dissociated from 8-day chick embryos. For the experiments
involving CRISPR/Cas9 gene editing (see Figs. 4 and 5), cells
dissociated from 11-day chick embryos were used because they
appeared healthier after transfection. In either case, recordings were
made from cultures on embryonic equivalent days 15–18. No physiological differences between cells cultured on either time frame were
detected in these experiments. Cells were plated on poly-L-ornithinetreated dishes at a density of 2.5 ⫻ 105 cells per 35-mm dish. Retinal
cells were initially plated in Dulbecco’s modified Eagle’s medium
(DMEM; Life Technologies) supplemented with 5% fetal calf serum
(Sigma, St. Louis, MO) and 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM glutamine (Life Technologies). One day after
plating, DMEM was replaced with Neurobasal medium (Life Technologies) supplemented with 1% B-27 nutrient medium and penicillin-streptomycin-glutamine (Life Technologies). Cells were fed every
other day for 2 weeks and then properly disposed of. Amacrine cells
were identified on the basis of their morphology as previously described (Gleason et al. 1993).
RT-PCR. Pools of five amacrine cells from culture dishes rinsed in
Hanks’ solution were collected by aspiration into siliconized (Sigmacote; Sigma) glass micropipettes. The pipette tips were broken in PCR
tubes containing 10 l of oligo(dT) Dynabeads (Ambion, Waltham,
MA). The cells were disrupted, and mRNA was bound to the oligo(dT) beads by vortexing for 8 min, after which mRNA was isolated
according to the manufacturer’s protocol. Amplification was immediately performed using the SuperScript III One-Step RT-PCR kit
with Platinum Taq from Invitrogen (Waltham, MA). Primers were as
follows: forward CFTR primer, AGAGTGTCATCCAAGCCTGC;
reverse, AGTGAGATTCGTGCTCGCTG. PCR product identity was
verified by sequencing.
Immunocytochemistry. Adult White Leghorn chickens (4 –7 wk
old) were euthanized using 250 mg/kg body wt pentobarbital sodium
via intraperitoneal injection and then decapitated. Eyes were enucleated and hemisected, and the eye cup was fixed in 4% paraformaldehyde for 1 h. After removal from the eyecup, the retina was washed
with 30 mM glycine in PBS (3 ⫻ 15 min). The retina was then
incubated with 30% sucrose in PBS overnight at 4°C. Retinas were
infiltrated in a 1:1 (vol/wt) mixture of 30% sucrose and optimal
cutting temperature compound (O.T.C.; Sakura Finetek, Torrence,
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CA) for 30 min at room temperature and then frozen in the same
mixture in a dry ice-isopentane bath. Tissue was cryosectioned at
~15–18 m on a Leica CM1850 cryostat (Wetzlar, Germany) and
mounted on Superfrost Plus micro slides (VWR, Radnor, PA). Sections were stored at ⫺20°C until use.
Sections were washed in PBS for 10 min to remove the sucroseO.C.T. mixture and then blocked with 5% normal goat serum in
dilution solution (PBS containing 0.1% saponin and 1% BSA) for 30
min at 4°C. The polyclonal CFTR antibody was raised against COOH
terminus (amino acids 1250 –1350) of the human CFTR (catalog no.
ab131553; Abcam, Cambridge, MA). The chicken CFTR sequence is
88% identical to the human antigen over residues 1250 –1350 with
only two nonconservative amino acid substitutions (Clustal 2.1). The
CFTR antibody was diluted (5 g/ml) in dilution solution and incubated on blocked sections for 2 h at room temperature. The secondary
goat anti-rabbit DyLight 488 antibody (no. 355552; ThermoFisher
Scientific) was diluted 1:500 in dilution solution and incubated in the
dark for 1 h at room temperature. Sections were mounted in ProLong
Diamond antifade mounting medium (Life Technologies). Sections
were viewed using an inverted Leica TCS SP2 spectral confocal
microscope (Leica Microsystems, Wetzlar, Germany) with a ⫻40
oil-immersion objective (1.25 N.A.). DyLight 488 was observed with
the 488-nm laser line with emission collection from 502 to 553 nm.
Images were acquired using the Leica LCS software package. Maximum intensity projection images of 125 z planes were adjusted using
ImageJ (NIH, Bethesda, MD).
Cultured cells were plated on polyornithine-coated glass coverslips
and fixed in 2% paraformaldehyde in PBS for 30 min at 4°C, washed
4 times with 30 mM glycine in PBS, and then permeabilized with
0.1% Triton X-100 in PBS for 5 min. Fixed cells were blocked with
5% normal goat serum in dilution solution (1% BSA-0.5% saponin in
PBS) for 30 min at 4°C. Anti-CFTR primary antibody was diluted in
dilution solution (1 g/ml) and incubated for 2 h at room temperature.
Goat anti-rabbit DyLight 488 secondary antibody was diluted 1:1,000
in dilution solution and incubated for 1 h at room temperature.
Coverslips were mounted using ProLong Diamond antifade mountant
with DAPI (ThermoFisher Scientific). Labeled cells were viewed on
an inverted Olympus IX70 microscope (Tokyo, Japan) fitted with a
SensiCam QE (Cooke, Kelheim, Germany). Images were captured
and analyzed using SlideBook 5.5 software (Intelligent Imaging
Innovations, Denver, CO). Antibody experiments were repeated at
least three times on cells or tissue derived from at least three different
cultures or animals, respectively.
Western blot analysis. Protein samples were prepared from chicken
brains as previously reported (McMains and Gleason 2011). Before
electrophoresis, protein samples were prepared in Laemmli buffer
containing 2% SDS, 5% 2-metcaptoethanol, 10% glycerol, 0.005%
bromophenol blue, and 62.5 mM Tris. Protein samples (20 g) in
Laemmli buffer were incubated at room temperature for 1 h. Proteins
were separated on an 8% bis-acrylamide-SDS gel with 10 l of
PageRuler prestained protein ladder (ThermoFisher Scientific). Separated proteins were transferred onto nitrocellulose membrane at 4°C
overnight. The following steps were carried out at room temperature.
The membranes were blocked with 5% normal goat serum and 1%
BSA in Tris-buffered saline with 0.1% Tween 20 (TBS-T) for 2 h.
Block solution was replaced with the diluted primary anti-CFTR
antibody (1:1,000) in TBS-T with 1% BSA and incubated for 2 h. The
AbExcel goat anti-rabbit secondary antibody conjugated with horseradish peroxidase (catalog no. ab97051; Abcam) was diluted (1:
50,000) in TBS-T with 1% BSA. The membrane was incubated with
the secondary antibody for 1 h and then washed in TBS-T. Western
blot was visualized using the Clarity chemiluminescence kit (Bio-Rad,
Hercules, CA) and the ChemiDoc XRS⫹ system (Bio-Rad). Western
blot images were captured using Image Lab software (Bio-Rad).
Electrophysiology. Culture dishes were mounted on the stage of an
inverted Olympus IX-70 microscope. A reference Ag-AgCl pellet in
3 M KCl was connected to the dish via a 3 M KCl and agarose-filled
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glass bridge. Patch pipettes with tip resistance values of 8 –11 M⍀
were pulled from thick-walled borosilicate glass (Sutter Instruments,
Novato, CA) using a P-97 micropipette puller (Sutter Instruments).
Electrophysiology experiments were performed on amacrine cells in
the whole cell voltage-clamp mode using Axopatch-1D patch clamp
(Molecular Devices, Sunnyvale, CA) and Clampex 9.2 software
(Molecular Devices). Whole cell data were filtered by the voltageclamp amplifier at 2 kHz and digitized at 5 kHz with either a Digidata
1322A or Digidata 1440A (Molecular Devices). Recordings were
rejected if the membrane resistance fell below 500 M⍀. Series
resistance (typical range 10 –25 M⍀) values were monitored throughout the experiments and were typically stable. If large changes
(⬎20%) did occur, the data were discarded. For voltage-ramp experiments, cells were held at ⫺70 mV and a voltage ramp was delivered
(⫺90 to ⫹50 mV over 200 ms) first in the absence of GABA and then
repeated in the presence of GABA. Before leak subtraction, corrections were made for errors due to the liquid junction potential
(estimated using the pClamp calculator, ⫺13 mV) and the series
resistance (as estimated by Clampex). Data were leak-subtracted by
subtracting the current in response to the first voltage ramp from the
current in response to the second voltage ramp and in the presence of
GABA. The electrophysiological evaluation of transfected and control
amacrine cells was done on amacrine cells derived from four separate
transfections. Experiments were carried out at room temperature.
Solutions. Unless otherwise specified, reagents were obtained from
Sigma-Aldrich. For electrophysiological recordings conducted under
Cl⫺-free conditions (see Fig. 2), the external solution contained (in
mM) 145.0 Na-methanesulfonate, 5.6 glucose, and 10.0 HEPES.
External solutions were adjusted to pH 7.4 with NaOH. The internal
zero-Cl⫺ solution contained (in mM) 145.0 Cs-methanesulfonate and
10.0 HEPES. The outflow was positioned near the KCl-containing
bridge to minimize any effect of Cl⫺ leaking from the bridge into the
bath. Voltage-ramp experiments were done in tetraethylammonium
(TEA)-Cl external solution containing (in mM) 116.7 NaCl, 5.3 KCl,
20.0 TEA-Cl, 3.0 CaCl2, 0.41 MgCl2, 10.0 HEPES, and 5.6 glucose.
The TEA-Cl external solution was supplemented with 300 nM TTX
(Abcam) and 50 M LaCl3 to block voltage-gated sodium and
calcium channels, respectively. The internal pipette solution for voltage-ramp experiments contained (in mM) 100.0 Cs-acetate, 10.0
CsCl, 0.1 CaCl2, 2.0 MgCl2, 10.0 HEPES, and 1.0 EGTA. Internal
recording solutions were adjusted to pH 7.4 with CsOH. Pipette
solutions were supplemented with an ATP regeneration system containing 50 U/ml creatine phosphokinase, 20 mM creatine phosphate, 1
mM ATP disodium, 3 mM ATP dipotassium, and 2 mM GTP
disodium. The CFTR inhibitors glibenclamide (Sheppard and Welsh
1992) and CFTRinh-172 (Ma et al. 2002) were prepared as 10 mM
stocks in DMSO and then diluted to their final concentrations in the
appropriate external solution. External solutions were controlled by a
ValveLink pinch valve pressurized perfusion system (Automate Scientific, Berkeley, CA). For GABA “pulse” experiments (see Fig. 2),
solution changes were achieved with a computer-controlled automated SF-77B perfusion fast stepper (Warner Instruments, Hamden,
CT). Experiments involving voltage ramps during exposure to GABA
were done with perfusion via a Perfusion Pencil (AutoMate, Berkeley,
CA) positioned near the recorded cell. As a control, cells were
routinely exposed to NO-free, low-pH solution (McMains and Gleason 2011), and none of the results reported in this article were
reproduced using this treatment. NO was prepared by bubbling Fisher
ultra-distilled pure water for 15 min with argon, followed by bubbling
with pure NO gas for 15 min. NO (30 –50 l) was injected into the
perfusion line and has been previously estimated to reach the recorded
cell in ~3 s and to remain for ~3–5 s (Hoffpauir et al. 2006).
CRISPR/Cas9. To genetically knockdown CFTR, we employed the
CRISPR/Cas9 system, developed by Ran et al. (2013), to introduce
insertions/deletions (indels) into the CFTR gene and disrupt CFTR
protein expression. The plasmid pSpCas9(BB)-2A-GFP was a gift
from Feng Zhang (Addgene plasmid no. 48138). The single guide

(sg)RNA was designed to target the 7th exon of the CFTR gene using
the web tool CRISPR (https://crispr.mit.edu). The corresponding
amino acid sequence includes intracellular loop 2, which is reported to
interact with one of the nucleotide binding domains (Mornon et al.
2008). Mutational analysis reveals roles in channel activity with a
19-amino acid deletion producing alterations in conductance states
(Xie et al. 1995). Missense mutations introduced into intracellular
loop 4, which also interacts with nucleotide binding domains, produce
changes in CFTR channel gating (Cotten et al. 1996). Oligos were
synthesized by Integrated DNA Technologies (Coralville, IA) and
inserted into pSpCas9(BB)-2A-GFP according to Ran et al. (2013) to
generate pCRISPR-CFTR. The primers used to generate the sgRNA
were CFTR E7 forward, caccgCTATTGCTGGGAAGATGCAA and
CFTR E7 reverse, aaacTTGCATCTTCCCAGCAATAg. Transfections were performed using the Amaxa Nucleofector 2b from Lonza
(Basel, Switzerland). Aliquots of 8 ⫻ 106 retinal neurons in suspension were transfected according to the manufacturer’s protocol. Transfection efficiency was ~10 –20%. Cells transfected with (BB)-2A-GFP
(no sgRNA) served as a negative control along with nontransfected
cells.
To detect indels (insertions/deletions) in the 7th exon of CFTR by
nonhomologous end joining induced by Cas9-mediated doublestranded DNA cleavage, genomic DNA (gDNA) from single transfected dishes or single transfected amacrine cells was isolated using
the Arcturus PicoPure kit (ThermoFisher Scientific). The 7th exon of
CFTR was PCR amplified using Q5 Hot Start High-Fidelity DNA
polymerase (New England Biolabs, Ipswich, MA) and primers that
were designed to anneal in regions flanking the 7th exon (forward,
AGTTCTGCTGGTAGTGAGTTG; reverse, GCGTGCTTACTTTATGGAGG). Correct PCR amplification was verified by sequencing
(Eurofins Genomics, Louisville, KY). TthRecA (New England Biolabs), along with its cofactor ATP, was added to the amplification mix
to improve specificity and yield (Shigemori et al. 2005). PCR products
(394 bp) from pCRISPR-CFTR transfections and pSpCas9 transfections were used in the T7 endonuclease I (T7E1) mutation detection
assay (New England Biolabs), which recognizes and cleaves mismatched double-stranded DNA. PCR products from each gDNA amplification were denatured and slowly reannealed to allow heteroduplex formation. Each heteroduplexed DNA sample was digested with
T7E1 (10 units) for 30 min at 37°C. T7E1-digested DNA (50 ng) was
separated by 2% agarose gel electrophoresis, stained with ethidium
bromide, and visualized using the ChemiDoc XRS⫹ system (BioRad). Images were captured and analyzed using Image Lab software
(Bio-Rad).
To confirm that the level of CFTR protein was diminished by the
CRISPR/Cas9 edit, CFTR antibody labeling was evaluated for transfected and control amacrine cells. Green fluorescent protein (GFP)
fluorescence in cells transfected with pCRISPR-CFTR did not withstand fixation, making identification of transfected cells unreliable. To
overcome this, the GFP gene in pSpCas9(BB)2A-GFP was replaced
with tdTomato gene from the plasmid tdTomato-N1 to create
pSpCas9td. The tdTomato-N1 was a gift from Michael Davidson and
Roger Tsien (unpublished; Addgene plasmid no. 54642). As described
above, the sgRNA targeting Cas9 to the 7th exon of CFTR was then
inserted into pSpCas9td to create pCRISPR-CFTRtd. Cells transfected
with either pSpCas9td or pCRISPR-CFTRtd were fixed and immunolabeled for CFTR as described above.
Data analysis. CFTR labeling of transfected and control amacrine
cells was analyzed using SlideBook software (Intelligent Imaging
Innovations). A lower threshold mask corresponding to the CFTR
channel was created based on nontransfected and secondary-only cell
images. The CFTR mask was then applied to images of cells transfected with pSpCas9tdTomato and pCRISPR-CFTRtd (see Fig. 4).
The relatively thick cell bodies were removed from the CFTR mask in
all images. The CFTR mask was also removed from any areas of the
images that did not have any tdTomato fluorescence (arising from
nontransfected cells in the dish). Only processes with tdTomato ex-
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pression were used for analysis. SlideBook software automatically
calculated CFTR mask descriptive statistics for CFTR object number
(⬎2 pixels), CFTR object area, CFTR sum intensity, and tdTomato
sum intensity. Welch’s t-tests were performed on all mask data using
Prism 7 (GraphPad Software, La Jolla, CA). The analysis was done
separately for cell bodies. Other data were analyzed as follows. For
multiple comparisons, the one-way ANOVA with Tukey’s post hoc
multiple comparisons test (see Figs. 3 and 5) was used. Pairwise
comparisons were made with the paired t-test (see Fig. 2). Data are
means ⫾ SE. The P value for significance was ⬍0.05.
RESULTS

To determine whether CFTR is expressed by amacrine cells,
mRNA from pools of five amacrine cells was amplified by
RT-PCR using CFTR gene-specific primers. A single PCR
product was produced at the correct size (121 bp; Fig. 1A), and
sequencing confirmed that it was from CFTR. To determine
whether the CFTR protein is expressed, a polyclonal antibody
raised against human CFTR was identified that recognizes a
single band of the appropriate molecular mass (168 kDa) in
chicken brain homogenate (Fig. 1B). In culture, the antibody
labeled amacrine cells both at the cell body and in neuronal
processes (Fig. 1C). Cone photoreceptor cells were also present
in our cultures, and although they lack outer segments, they are
easily identifiable by their characteristic morphology and the
possession of an oil droplet (Fig. 1D, arrow) (Adler et al. 1984;
Wilson and Gleason 1991). These cells had a distinctive
labeling pattern where CFTR immunoreactivity was especially
concentrated in the ellipsoid region of the cell, a domain rich
with mitochondria (Fig. 1D, asterisk). Presumably, this pattern
reflects a strong localization of CFTR to mitochondrial membranes.

A

B
bp
400

C
kDa

In sections of adult chicken retina, strong CFTR labeling
was also seen in photoreceptor ellipsoids (Fig. 1E) as well as in
the outer plexiform layer, where synapses between photoreceptors and horizontal and bipolar cells are found. Some CFTR
labeling can be seen throughout the inner nuclear layer where
horizontal, bipolar, and amacrine cell bodies reside. In this
layer, the most distinctive labeling is in the inner one-third to
one-half, where amacrine cell bodies predominate. Labeling
was found throughout the inner plexiform layer, where amacrine as well as bipolar cells make their synapses. Additionally,
there was a band of more intense labeling near the outer margin
of the inner plexiform layer (Fig. 1E, arrowheads). Cells in the
ganglion cell layer as well as the ganglion cell axons were also
labeled. Together, these results indicate that the CFTR protein
is expressed by amacrine cells both in culture and in the intact
retina. Furthermore, CFTR is broadly expressed in the retina
and thus has the potential to influence retinal function at
multiple sites.
To investigate the role of the CFTR in the NO-dependent
release of Cl⫺ from acidic organelles, experiments were done
in the absence of extracellular and intracellular (pipette) Cl⫺ to
isolate the intracellular store as the only source of Cl⫺. Washout of cytosolic Cl⫺ was verified by the absence of a response
to pulses of GABA (20 M; Fig. 2A, top left) with the cell held
at ⫺70 mV. After NO, small GABA-gated inward currents are
transiently observed, which represent Cl⫺ released from the
internal store and then exiting the cell via the open GABAA
receptors (Hoffpauir and Gleason 2002). NO-dependent
GABA-gated currents disappear during the next recording of
five GABA pulses. The effects of two cell-permeable CFTR
inhibitors were tested: glibenclamide (20 M) and CFTRinh-
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Fig. 1. Amacrine cells express CFTR mRNA and protein. A: RT-PCR product amplified from a pool of 5
amacrine cells at the predicted size (121 bp). Identity of
the product was confirmed by sequencing. B: Western
blot of chicken brain homogenate probed with a polyclonal antibody raised against human CFTR. A prominent band is observed near the predicted molecular mass
of 168 kDa. C: an amacrine cell labeled with the
anti-CFTR antibody. D: a cone cell in culture (top),
identified by its oil droplet (arrow), has a high density of
labeling in the ellipsoid (asterisk); bottom, secondaryonly control. Scale bars are 10 m. E: anti-CFTR
labeling in a section of adult chicken retina. Strong
labeling can be seen in the ellipsoid (E) region of the
photoreceptors (PR), as observed in culture. Outer plexiform layer (OPL) labeling can also be observed, possibly due to CFTR expression in photoreceptor terminals. Labeling can also be observed for cells in the inner
nuclear layer (INL) as well as the ganglion cell layer
(GCL). In the inner plexiform layer (IPL), there is
labeling throughout, but labeling is especially distinctive for a band of processes near the inner border of the
inner nuclear layer (arrowheads). A secondary-only
control is shown at right. Experiments were performed
on at least 3 separate cultures and retinas from at least
3 different animals.
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Fig. 2. Inhibitors of CFTR block the release of Cl from acidic organelles. A: representative traces from an amacrine cell voltage-clamped at ⫺70 mV with pulses
of GABA (20 M) applied as indicated by the horizontal bars. Recordings were made in Cl⫺-free internal and external solutions. The absence of GABA-gated
currents indicates that cytosolic Cl⫺ has washed out. Under control conditions, NO elicits a small, GABA-dependent inward current, which represents newly
available cytosolic Cl⫺ exiting through open GABA receptors. In the same cell but in the presence of glibenclamide (20 M), no GABA-gated currents appear
after NO. B: mean current amplitudes before and after NO are plotted for control and glibenclamide data (n ⫽ 5). *P ⬍ 0.05, paired t-test. C: the same experiment
as in A, but data are shown from a different amacrine cell and the effectiveness of CFTRinh-172 (10 M) was tested. D: mean current amplitudes are plotted
for the GABA-gated currents in the presence and absence of CFTRinh-172 (n ⫽ 7). ***P ⬍ 0.001, paired t-test. Individual data points are plotted with the dotted
line indicating the mean and the bars indicating SE.

172 (10 M). Glibenclamide functions as an internal pore
blocker and is also known to inhibit ATP-dependent K⫹
channels (Sheppard and Robinson 1997; Sheppard and Welsh
1992). CFTRinh-172 affects CFTR channel gating (Kopeikin et
al. 2010) and can affect mitochondrial function, although not in
the time frame of exposure in these experiments (Kelly et al.
2010). For both inhibitors, cells that had demonstrated NOdependent Cl⫺ release under control conditions were no longer
responsive to NO in the presence of the inhibitors (Fig. 2, A
and C, bottom right traces). On average, the CFTR inhibitors
significantly blocked the ability of NO to generate GABAgated currents due to release of internal Cl⫺ (control current:
36.2 ⫾ 18.2 pA, n ⫽ 5; glibenclamide current: 2.0 ⫾ 1.3 pA,
n ⫽ 5, P ⬍ 0.05, paired t-test; control current: 16.8 ⫾ 2.6 pA,
n ⫽ 7; CFTRinh-172 current: 1.1 ⫾ 0.6 pA, n ⫽ 7, P ⬍ 0.001,
paired t-test).
To confirm that glibenclamide and CFTRinh-172 were inhibiting the NO-dependent release of Cl⫺, we estimated the Cl⫺
content of the cytosol by measuring the reversal potential of the
leak-subtracted GABA-gated current (EREV-GABA) in solutions
containing normal Cl⫺ concentrations. Under control conditions, NO caused a shift in EREV-GABA of the current in the
positive direction, indicating an increase in cytosolic Cl⫺ (Fig.
3, A and C). In the presence of either glibenclamide or
CFTRinh-172, however, the shifts in EREV-GABA were suppressed (control: 26.7 ⫾ 4.5 mV, n ⫽ 9; glibenclamide:
1.6 ⫾ 1.2 mV, n ⫽ 7; CFTRinh-172: ⫺0.3 ⫾ 0.5 mV, n ⫽ 9,
P ⬍ 0.0001, 1-way ANOVA with Tukey’s multiple comparisons test; Fig. 3F). When the inhibitors were applied first,
NO-dependent shifts in EREV-GABA could still be observed after
the wash (Fig. 3, Ei–Eiv), indicating that the effects of the
inhibitors were at least partially reversible. Another CFTR

inhibitor, GlyH101, was also tested, but it inhibited the GABAgated currents, making measurements of EREV-GABA difficult.
This unexpected effect of GlyH101 may be due to its activity
as an external Cl⫺ channel pore blocker (Sonawane and Verkman 2003). Nonetheless, the effects of the other inhibitors
suggest that CFTR activity is required for the NO-dependent
release of Cl⫺ from acidic organelles.
To confirm a role for CFTR, we used a CRISPR/Cas9 gene
editing strategy to knock down expression of the protein. To
confirm that Cas9 was targeted to the 7th exon of CFTR to
induce indels (insertions/deletions), the 7th exon was PCR
amplified from either single transfected amacrine cell genomic
DNA (Fig. 4Ai) or pooled genomic DNA from cultures (Fig.
4Aii; containing both transfected and nontransfected cells) that
were transfected with either pCRISPR-CFTR or pSpCas9. The
PCR product (~394 bp) was then analyzed for indels in the
CFTR gene using the T7 endonuclease I (T7E1) mutation assay
(EnGen Mutation kit; New England Biolabs). T7E1 cleaved
heteroduplexed PCR products amplified from cells transfected
with pCRISPR-CFTR into appropriate-sized fragments (~228
and ~166 bp) but did not cleave the PCR products amplified
from cells transfected with pSpCas9 for samples derived from
both transfected individual amacrine cells (Fig. 4Ai) or transfected cultures (Fig. 4Aii). These results demonstrate that
pCRISPR-CFTR is effective at targeting Cas9 to the 7th exon
of CFTR to induce indels, which lead to the reduction in CFTR
expression.
To assess the effectiveness of knocking down CFTR expression by targeting Cas9 to the 7th exon of the CFTR gene with
the CFTR-specific sgRNA, amacrine cells transfected without
the sgRNA (pSpCas9td) or with the sgRNA (pCRISPRCFTRtd) were labeled using the same anti-CFTR antibody as
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in Fig. 1 (Fig. 4, B–G). Cells that were transfected with
pCRISPR-CFTRtd had a 69% reduction in the total CFTRlabeled area in processes (pSpCas9td: 14.58 ⫾ 1.7 m2, n ⫽
10; pCRISPR-CFTRtd: 4.5 ⫾ 1.1 m2, n ⫽ 10, P ⫽ 0.0001,
Welch’s t-test; Fig. 4H), a ~34% reduction in CFTR-labeled
object size (pSpCas9td: 71.27 ⫾ 5.74 nm2, n ⫽ 10; pCRISPRCFTRtd: 47.01 ⫾ 5.24 nm2, n ⫽ 10, P ⫽ 0.006, Welch’s t-test;
Fig. 4I), and a 35% reduction in the CFTR object fluorescence
intensity [pSpCas9td: 5,319 ⫾ 419.8 arbitrary units (A.U.),
n ⫽ 10; pCRISPR-CFTRtd: 3,472 ⫾ 425.2 A.U., n ⫽ 10, P ⫽
0.006, Welch’s t-test; Fig. 4J]. The tdTomato fluorescence
intensity within the area of CFTR labeling (CFTR objects) was
not significantly different (pSpCas9td: 4,430 ⫾ 828.4 A.U.,
n ⫽ 10; pCRISPR-CFTRtd: 3,365 ⫾ 553.2 A.U., n ⫽ 10, P ⫽
0.3, Welch’s t-test; Fig. 4K). Cell bodies were analyzed separately, and CFTR fluorescence intensity was reduced by 18%
in the pCRISPR-CFTRtd-transfected cells compared with control (pSpCas9td; 100,994 ⫾ 6,065 A.U., n ⫽ 9; pCRISPRCFTRtd: 82,444 ⫾ 5,496 A.U., n ⫽ 10, P ⫽ 0.04).
To assess the physiological effects of the CFTR gene editing, voltage-clamp recordings were made from amacrine cells
transfected with pCRISPR-CFTR, with the construct minus the
guide RNA sequence (pSpCas9), GFP-negative cells from a
transfection (⫺GFP), and nontransfected cells. Amacrine cells
were recorded from 4 –7 days after transfection and plating.
EREV-GABA was determined by measuring the leak-subtracted
current produced by voltage ramps delivered in the presence of

GABA. NO-dependent positive shifts in EREV-GABA were not
observed in amacrine cells transfected with pCRISPR-CFTR
(mean shift ⫺3.6 ⫾ 2.7 mV, n ⫽ 26; Fig. 5, A and E), but
NO-dependent positive shifts in EREV-GABA were observed for
all the control cell populations (mean shifts; pSpCas9:
13.5 ⫾ 3.0 mV, n ⫽ 22; –GFP: 14.1 ⫾ 3.5, n ⫽ 16; nontransfected: 19.9 ⫾ 4.4 mV, n ⫽ 10; Fig. 5, B–D). Mean shift values
for cells transfected with the full construct were significantly
different from those observed in each of the control cell
populations (P ⬍ 0.0001, 1-way ANOVA, Tukey’s multiple
comparisons test; Fig. 5F). In some pCRISPR-CFTR cells, NO
produced a negative shift in EREV-GABA, suggesting that Cl⫺ is
leaving the cytosol. Similar observations were made in the
inhibitor experiments (Fig. 3). We currently do not know the
mechanism underlying this observation, but it might be a
reflection of the interactions between transport mechanisms
and an imbalance generated by the reduction in CFTR expression (or function).
DISCUSSION

Amacrine cell RT-PCR and immunocytochemistry experiments demonstrate that these cells express CFTR mRNA and
protein, respectively. Established inhibitors of CFTR, glibenclamide (Sheppard and Welsh 1992) and CFTRinh-172 (Ma et
al. 2002), prevent the release of Cl⫺ from acidic organelles by
NO, and a reduction in CFTR expression by using CRISPR/
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Fig. 4. CRISPR/Cas9-mediated editing of the CFTR gene reduces the expression of CFTR. Ai: T7 endonuclease I (T7EI)-digested heteroduplexed PCR products,
which contained indels (insertions/deletions) near the predicted lengths (228 and 168 bp), that were amplified from genomic DNA extracted from single amacrine
cells transfected with pCRISPR-CFTR and pSpCas9. T7EI only digested heteroduplexed PCR products amplified from the amacrine cell transfected with
pCRISPR-CFTR. Aii: T7EI-digested heteroduplexed PCR products, containing indels near the predicted lengths (228 and 168 bp), that were amplified from
genomic DNA extracted from a population of cultured retinal cells transfected with pCRISPR-CFTRtd. T7EI did not digest heteroduplexed PCR products
amplified from genomic DNA extracted from a population of cells transfected with pSpCas9td. B–G: representative amacrine cells transfected with pSpCas9td
(B–D) and pCRISPR-CFTRtd (E–G). Anti-CFTR labeling (C and F) and merged images (D and G) are shown. White boxes in B–G are shown at higher
magnification in Bi–Gi, respectively. Scale bars are 10 m (B–G) and 5 m (Bi–Gi). H–K: data from analyzed processes from cells transfected with the
pSPCas9td construct and processes from cells transfected with pCRISPR-CFTRtd. Shown are mean total CFTR area (H), the mean CFTR object size (I), the mean
CFTR intensity (J), and the mean tdTomato intensity within the CFTR object domains (K); n ⫽ 10 for both groups; A.U., arbitrary units. **P ⬍ 0.01; ***P ⬍
0.001, Welch’s t-test. Individual data points are plotted with the longer center line indicating the mean and the shorter bars indicating SE. This experiment was
repeated on cells from 3 different transfections. Similar qualitative results were obtained from each experiment. However, the transfection with the least
transfection-related debris was chosen for quantitative analysis to maximize the quality of the data.

Cas9 to disrupt the CFTR gene also prevents NO from releasing internal Cl⫺. Together these results indicate that CFTR is
required for the NO-dependent release of Cl⫺ from acidic
organelles.
Resting our conclusions on pharmacology alone would be
less compelling, because although they are well established to
inhibit CFTR currents, both glibenclamide and CFTRinh-172
are known to inhibit the function of other channels. For
example, glibenclamide also blocks ATP-sensitive K⫹ channels (Sturgess et al. 1988), and CFTRinh172 blocks the volumesensitive outwardly rectifying Cl⫺ conductance (Melis et al.
2014). Fortunately, the channels other than CFTR that these
inhibitors affect do not overlap such that the similar effects of
the inhibitors shown in the present study are consistent with

inhibition of CFTR. The pharmacology of human CFTR is
fairly well worked out, but there is evidence that the pharmacology of this protein differs across species. For example,
CFTRinh-172 has little inhibitory effect on shark CFTR but is
effective (in order of declining effectiveness) on human, killifish, and pig CFTR (Stahl et al. 2012). Limited information is
available on chicken CFTR; however, 300 M glibenclamide
has been shown to partially inhibit a current that is elicited by
parathyroid hormone and is dependent on Cl⫺ (Laverty et al.
2003), and CFTRinh-172 (20 M) has been shown to inhibit
CFTR (Laverty et al. 2012) in chicken proximal tubule monolayers. Functional differences between human and chicken
have been observed for CFTR single-channel currents measured in planar bilayers (Aleksandrov et al. 2012). That study

J Neurophysiol • doi:10.1152/jn.00511.2017 • www.jn.org
Downloaded from journals.physiology.org/journal/jn at LSU Louisiana State Univ (130.039.060.163) on September 22, 2021.

CFTR AND CHLORIDE RELEASE

600

B

Current (pA)

400

400

50 mV

200

-70 mV

Pre-NO
Post-NO

-90 mV

0
-100

-60

-40

-20

-10

0

-20

-10

0

Voltage (mV)

300

Non-transfected
200

Current (pA)

400

Current (pA)

-40

-200

– GFP

200
Pre-NO
Post-NO

0
-60

-40

-20

-10

0

100
0

Pre-NO
Post-NO
-100

-80

-60

-100

-40

-20

-10

0

Voltage (mV)

Voltage (mV)
-200
-300

-400

F
Mean shift in EREV-GABA (mV)

E

Pre-NO
Post-NO
-80

D

600

200

0

Voltage (mV)

-400

-200

pSpCas9

GABA

-200

C

600

pCRISPR-CFTR

Current (pA)

A

2849

****

60
50
40
30
20

Fig. 5. CFTR is required for the NO-dependent
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showed that the single-channel conductance and the probability
of opening was higher for chicken CFTR than for human
CFTR, but it is not known if or how this might affect the
pharmacology of this protein. We found that 20 M glibenclamide was sufficient to block the NO-dependent release of Cl⫺
from acidic organelles. The IC50 values for glibenclamide
inhibition of human CFTR are generally in the range of 20 – 40
M, depending on the expression system (Sheppard and Robinson 1997; Sheppard and Welsh 1992), and in guinea pig
cardiac myocytes, the value ranges from 25 to 38 M, depending on the method of current activation (Tominaga et al. 1995).
We also found that glibenclamide and CFTRinh-172 are reversible, but studies on human CFTR have found that both of these
inhibitors can be difficult to reverse. However, context seems
to matter, because glibenclamide is easily reversible when
applied to excised inside-out membrane patches of human
CFTR expressed in mammary epithelial cells (Sheppard and
Robinson 1997) but not for whole cell recordings from NIH
3T3 cells expressing human CFTR (Sheppard and Welsh
1992). Our recordings were made in the whole cell configurations, but we detected changes due to the functioning of
chicken CFTR on intracellular membranes. It is possible that
species differences and/or the intracellular (vs. plasma mem-

– GFP Non-transfected

brane) environments play a role in the reversibility that we
observe.
Our present work demonstrates that functional CFTR is
necessary for NO to increase cytosolic Cl⫺, but is it sufficient?
Our previous research demonstrated that the NO-dependent
release of Cl⫺ from acidic organelles depends on transient
cytosolic acidification (McMains and Gleason 2011) and the
maintenance of compartmental acidic environments (Krishnan
and Gleason 2015). Clearly, there are other physiological
factors involved, and further complexity may originate from
CFTR itself.
CFTR can be regulated by multiple enzymes (Dahan et al.
2001), including protein kinase C (Jia et al. 1997), some
tyrosine kinases (Billet et al. 2016), and AMP-dependent
protein kinase (Hallows et al. 2000), as well as phosphatases
(Luo et al. 1998). At the most fundamental level, however,
CFTR activity is dependent on ATP binding and hydrolysis
and is substantially enhanced by phosphorylation via protein
kinase A (PKA). Under our recording conditions, ATP should
be readily available; however, these experiments were done
without overt activation of adenylate cyclase or addition of
cAMP. One possibility is that NO triggers channel opening in
the absence of PKA-dependent phosphorylation. Alternatively,
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resting PKA activity levels may be relatively high in amacrine
cells. Interestingly, two reports on the role of CFTR in neuronal cytosolic Cl⫺ homeostasis demonstrate effects of CFTR
inhibitors on cytosolic Cl⫺ in the absence of stimulated PKA
activity (Morales et al. 2011; Ostroumov et al. 2011), implying
significant baseline CFTR (and possibly PKA) activity in those
neurons. A third possibility is that the Ca2⫹ elevations that we
know are generated by NO in amacrine cells (Maddox and
Gleason 2017) activate the Ca2⫹-sensitive adenylate cyclase,
adenylate cyclase 1. CFTR activation via adenylate cyclase 1
has been previously demonstrated (Billet and Hanrahan 2013).
Importantly, we have evidence that adenylate cyclase 1 is
functionally expressed in amacrine cells and that there are
significant levels of basal activity of both adenylate cyclase 1
and PKA in these cells (Tekmen and Gleason 2010). Further
experiments examining the effects of PKA activators and
inhibitors on cytosolic Cl⫺ and its regulation by NO would
shed light on the possibility that cytosolic Cl⫺ and cAMP
levels are linked.
CFTR has physical and physiological interactions with multiple classes of proteins. Among these are PDZ domain scaffolding proteins, which can facilitate interactions with other
proteins and potentially establish signaling complexes (reviewed in Li and Naren 2010). Functional interactions have
also been demonstrated for CFTR and soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) proteins
(reviewed in Tang et al. 2011). CFTR is also known to
functionally interact with the renal outer medullary K⫹ channel
ROMK, an inward rectifying K⫹ channel (Yoo et al. 2004), the
epithelial Na⫹ channel ENaC (Stutts et al. 1997), Cl⫺-bicarbonate exchangers (Shumaker et al. 1999), and Na⫹-bicarbonate exchangers (Ko et al. 2002). Additionally, reciprocal inhibitory interactions have been demonstrated for anoctamin-1,
a Ca2⫹-activated Cl⫺ channel, and CFTR in epithelial cells
(Ousingsawat et al. 2011), suggesting that the balance of Ca2⫹
and cAMP signaling can determine the level of Cl⫺ flux
(Kunzelmann and Mehta 2013). Thus there is precedence for
CFTR working as a part of a regulatory complex, which is
consistent with the possibility that CFTR is necessary but
perhaps functions in combination with other proteins in amacrine cells.
Epithelial cells employ an orchestra of transport mechanisms
that by their apical or basal expression patterns regulate the
distribution of ions across tissues. Neurons have a similarly
complex set of transport mechanisms, but most of these regulate ion concentrations across cellular membranes and have the
potential to generate nonuniform distributions of transported
ions in the cytosol. Cytosolic Ca2⫹, for example, is so tightly
regulated and buffered that its potential for diffusion is highly
limited. The cellular scenario for Cl⫺ transport, regulation, and
distribution is much more incomplete. Although several families of Cl⫺ channels and transporters have been identified
(Stauber and Jentsch 2013), relatively little is known about
their cellular distributions and functional interactions, especially in the context of neurons. Learning more about this will
be of particular importance in understanding the function of
amacrine cells, because some are capable of highly localized
synaptic signaling (Grimes et al. 2010, 2015).
In this study, we have demonstrated a neuronal role for
CFTR in regulating cytosolic Cl⫺ in response to NO, thus
regulating the strength or even the sign of postsynaptic

GABAergic and glycinergic responses. The involvement of
CFTR in this fundamental aspect of neuronal physiology contributes to filling the gap in our understanding of neuronal Cl⫺
regulation. Continued investigations into the function of CFTR
in the neuronal environment will likely reveal other roles for
this multifunctional protein.
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